Interestingly, IRF9 is thought to contribute to p53-mediated upregulation of IFNs in response to viruses (Muñoz-Fontela et al., 2008), but may also promote cancer cell survival by enhancing IL6 expression and STAT3 activation (Nan et al., 2018). The gene discussed is TP53; the disease is cancer.